The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Toronto-based Apotex sued the U.S. government after the FDA banned imports from two of the generic drug maker’s plants. An arbitration panel ruled in favour of the U.S. this week.
Toronto-based Apotex sued the U.S. government after the FDA banned imports from two of the generic drug maker’s plants. An arbitration panel ruled in favour of the U.S. this week.
(Peter Power/The Globe and Mail)

In free-trade deals, sovereignty rules

A frequent criticism of treaties that allow corporations to sue governments is that they may force countries to weaken health or environmental laws.

Those fears are now helping to fan European opposition to the investor-state dispute settlement (ISDS) provisions contained in the Canada-Europe free trade deal.